Growth Metrics

Armata Pharmaceuticals (ARMP) Return on Invested Capital (2017)

Historic Return on Invested Capital for Armata Pharmaceuticals (ARMP) over the last 1 years, with Q4 2017 value amounting to 1.67%.

  • Armata Pharmaceuticals' Return on Invested Capital changed N/A to 1.67% in Q4 2017 from the same period last year, while for Dec 2017 it was 1.67%, marking a year-over-year change of. This contributed to the annual value of 1.68% for FY2017, which is 3400.0% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Return on Invested Capital stood at 1.67% for Q4 2017.
  • In the past 5 years, Armata Pharmaceuticals' Return on Invested Capital ranged from a high of 1.67% in Q4 2017 and a low of 1.67% during Q4 2017